Accessories: glycerin, activated carbon, sodium hydroxide.
【 characteristics 】 this product is colorless transparent liquid.
【 indications 】 this product is used only for: 1, there are risks cytomegalovirus infection may occur in organ transplant recipients of CMV disease.
2, treatment of immune function defects (including HIV/AIDS patients) in patients with CMV retinitis.
【 specification 】 20 ml: 0.25 g [storage] shading, airtight preservation.
【 package 】 ampoule packaging, 20 ml/branch.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Ganciclovir Injection is a potent antiviral pharmaceutical formulation primarily manufactured via <strong>chemical synthesis</strong>. Its core structure relies on the nucleoside analog mechanism to inhibit viral DNA polymerase. The active ingredient is characterized by the molecular formula <strong>C9H13N5O4</strong> and CAS No. <strong>82410-32-0</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Ophthalmology:</strong> Treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients.</li>
<li><strong>Hematology:</strong> Prophylaxis against CMV infection in solid organ transplant recipients.</li>
<li><strong>Infectious Disease:</strong> Management of severe systemic CMV infections in HIV/AIDS populations.</li>
</ul>
<h3>Precautions</h3>
<p>Strict clinical monitoring for bone marrow suppression, particularly neutropenia and thrombocytopenia, is mandatory. Storage requires protection from light at controlled room temperature (20°C–25°C). Personnel must handle with PPE due to potential carcinogenicity and mutagenicity risks.</p>